United States · Addiction Treatment startup
United States · Adial Pharmaceuticals
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
Funding reportedLast round: Post ipo equity
What company datasets say Adial Pharmaceuticals raised
Funding, as reported
Reported in all$34Min dollars
Rounds11
Last roundPost ipo equity
Last round dateMar 2024
Investors listed3
SEC Form D$38M sold, 19 filings, last Dec 2025
Addiction Treatment in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Adial Pharmaceuticals in front of investors. Or tell us what we have wrong.